FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,804,000 | -73.9% | 105,000 | -66.7% | 0.08% | -76.7% |
Q4 2017 | $6,905,000 | -71.9% | 315,000 | -47.6% | 0.36% | -74.2% |
Q3 2017 | $24,587,000 | +35.9% | 601,000 | 0.0% | 1.39% | +23.6% |
Q2 2017 | $18,096,000 | -16.7% | 601,000 | 0.0% | 1.13% | -21.6% |
Q1 2017 | $21,726,000 | -46.5% | 601,000 | -25.8% | 1.44% | -45.6% |
Q4 2016 | $40,589,000 | -23.8% | 810,000 | -20.2% | 2.64% | -18.8% |
Q3 2016 | $53,288,000 | +18.8% | 1,015,200 | -6.5% | 3.25% | +18.5% |
Q2 2016 | $44,873,000 | -4.4% | 1,085,200 | -6.1% | 2.75% | +4.7% |
Q1 2016 | $46,936,000 | -9.9% | 1,155,200 | -8.0% | 2.62% | +0.7% |
Q4 2015 | $52,091,000 | +190.6% | 1,255,200 | +7.8% | 2.60% | +149.9% |
Q3 2015 | $17,928,000 | -24.7% | 1,164,900 | +21.6% | 1.04% | -19.0% |
Q2 2015 | $23,794,000 | +24.1% | 957,900 | +14.1% | 1.29% | -10.8% |
Q1 2015 | $19,180,000 | -9.4% | 839,400 | +7.1% | 1.44% | -37.5% |
Q4 2014 | $21,168,000 | +133.3% | 784,000 | +1.3% | 2.31% | +82.3% |
Q3 2014 | $9,074,000 | -24.6% | 773,600 | 0.0% | 1.27% | -22.6% |
Q2 2014 | $12,029,000 | +19.2% | 773,600 | +50.7% | 1.64% | +4.5% |
Q1 2014 | $10,090,000 | – | 513,200 | – | 1.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|